Co-Authors
This is a "connection" page, showing publications co-authored by Chun Chao and Erin Hahn.
Connection Strength
3.563
-
Trends in HPV vaccine administration and HPV vaccine coverage in children by race/ethnicity and socioeconomic status during the COVID-19 pandemic in an integrated health care system in California. Vaccine. 2022 11 02; 40(46):6575-6580.
Score: 0.819
-
De-implementation and substitution of clinical care processes: stakeholder perspectives on the transition to primary human papillomavirus (HPV) testing for cervical cancer screening. Implement Sci Commun. 2021 Sep 23; 2(1):108.
Score: 0.762
-
Use of recommended posttreatment services for adolescent and young adult survivors of Hodgkin lymphoma. Cancer. 2019 May 01; 125(9):1558-1567.
Score: 0.632
-
A pragmatic randomized trial to compare strategies for implementing?primary HPV testing for routine cervical cancer screening in a large?healthcare system. Implement Sci. 2025 May 12; 20(1):21.
Score: 0.245
-
Evaluating the trend of time to colposcopy follow-up among women with a positive primary human papillomavirus screening result at Kaiser Permanente Southern California. Am J Obstet Gynecol. 2025 Mar 27.
Score: 0.243
-
Primary Human Papillomavirus Screening: Women's Perceptions of New Cervical Cancer Screening Recommendations. J Womens Health (Larchmt). 2024 Dec; 33(12):1614-1624.
Score: 0.234
-
A study protocol for a cluster randomized pragmatic trial for comparing strategies for implementing primary HPV testing for routine cervical cancer screening in a large health care system. Contemp Clin Trials. 2023 01; 124:106994.
Score: 0.206
-
Impact of COVID-19 on Cervical Cancer Screening Rates Among Women Aged 21-65 Years in a Large Integrated Health Care System - Southern California, January 1-September 30, 2019, and January 1-September 30, 2020. MMWR Morb Mortal Wkly Rep. 2021 Jan 29; 70(4):109-113.
Score: 0.182
-
Preventive health service use among survivors of adolescent and young adult cancer. Prev Med Rep. 2020 Dec; 20:101278.
Score: 0.180
-
Cervical Cancer Screening: Patient Perspectives on Transitioning to Primary High-Risk Human Papillomavirus Testing Alone. Perm J. 2024 Oct 24; 1-8.
Score: 0.059